Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I and II Clinical Trials of Agents for Cancer Prevention
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Synthetic hydrogel for satellite cell delivery to the dystrophic diaphragm
Interdisciplinary Research Training in Pain and Substance Use Disorders
Selection for Xmrk gene in Xiphophorus melanoma model
Studies to Evaluate the T0xic and Carcinogenic
Telecommunications and Electronic Mail Services
Recently added grants:
Neurodevelopmental Emergence of Callous-Unemotional Behavior Beginning in Infancy: Neural Markers and Environmental Risk and Protective Factors
Acute Use of Alcohol and Attentional Bias towards Suicide: An Experimental Test of the Attention-Allocation Model.
Structure/Function Studies of LILRs Enabled by a Bacterially-Derived Ligand
Mapping superior colliculus contributions to action selection and movement
Prostate cancer-associated SPOP mutations modulate innate immune response and immune checkpoint therapy
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN35160-8-0-1
Application #
7579646
Study Section
Project Start
2003-09-30
Project End
2009-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Phase I and II Clinical Trials of Agents for Cancer Prevention
/ University of California Irvine
$750,000
NIH 2007
N01 CA
Phase I and II Clinical Trials of Cancer Chemopreventive Agents
Meyskens, Frank Louis /
$1,577,000
NIH 2007
N01 CA
Phase I and II Clinical Trials of Agents for Cancer Prevention
/
Comments
Be the first to comment on this grant